CELLULAR PROCESSING OF DAMAGED DNA: ROLE IN ONCOGENESIS
受损 DNA 的细胞处理:在癌发生中的作用
基本信息
- 批准号:3479531
- 负责人:
- 金额:$ 69.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-06-05 至 1994-05-31
- 项目状态:已结题
- 来源:
- 关键词:DNA DNA damage DNA methylation DNA repair Escherichia coli HMG coA reductases acetylaminofluorene alpha fetoprotein ataxia telangiectasia cancer risk carcinogenesis chemical carcinogenesis chromatin chromosome aberrations chromosome translocation congenital aplastic anemia crosslink dwarfism embryo /fetus protein gene expression genetic manipulation genetic mapping genetic recombination genetic regulation genetic transcription globin human genetic material tag human tissue laboratory mouse metallothionein microinjections neoplasm /cancer genetics neoplastic cell nucleic acid biosynthesis nucleic acid sequence oncogenes plasmids psoralens pyrimidine dimers radiation carcinogenesis syndrome tissue /cell culture transfection ultraviolet radiation
项目摘要
Our ultimate objective is to understand how the processing of
damaged DNA in mammalian cells relates to carcinogenesis.
Using relatively short, defined DNA sequences containing well
characterized lesions, we have begun to analyze the intragenomic
"fine structure" of DNA repair in cultured cells. Having
discovered that certain regions of the nuclear genome repaired
more efficiently than others, we hypothesize that the efficiency
of repair of damage in mammalian chromatin depends upon the
type of lesion, its location in the genome and the functional state
of the DNA at the site of the lesion. Such specificity may
account for some of the profound differences soon in the
carcinogenic responses of different tissues and of the same tissue
in different organisms. Having developed assays sensitive enough
to detect repair of several different lesions, including pyrimidine
dimers and interstrand cross-links, in restriction fragments from
specific regions of the genome, we will compare the rate and
extent of repair in genes that differ levels of expression, time of
replication, genomic location and function. Examples include
protooncogenes and other inducible or developmentally activated
genes such as those for metallothioneins, alpha fetoprotein, fetal
and adult beta-globin and myosin heavy chain in differentiating
myoblasts. Chromatin conformation and methylation levels will
be assessed as possible determinants of proficient repair. Repair
and mutagenesis will be correlated in the same genes to
determine whether differential repair might account for
mutagenic changes related to carcinogenesis. Replication of
defined nucleotide sequences containing damage will be studied to
determine whether differential levels of replication occur in
particular genomic domains and whether daughter-strand
discontinuities occur in those sequences. Defined chimeric
plasmids containing lesions at unique sites will be used to
introduce genes into different genomic domains and to probe the
specific features of damage processing the increase the frequency
of stable transformation of human cells.
This research should contribute substantially to our understanding
of the basis for DNA damage processing deficiencies in certain
cancer-prone hereditary diseases and it should also result in new,
sensitive probes for the analysis of damage and repair in human
cells. In addition, our studies should help to interpret the role of
DNA damage in biologic end points such as survival, mutagenesis,
and carcinogenesis.
我们的最终目标是了解如何处理
哺乳动物细胞中的DNA损伤与癌症的发生有关。
使用相对较短的、定义的DNA序列,包含Well
特征损伤,我们已经开始分析基因组内
培养细胞DNA修复的“精细结构”。拥有
发现核基因组的某些区域修复了
比其他人更有效率,我们假设效率
哺乳动物染色质损伤的修复取决于
病变类型、其在基因组中的位置和功能状态
病变部位的DNA。这种专一性可能
解释了即将出现的一些深刻差异
不同组织和同一组织的致癌反应
在不同的生物体中。已经开发出足够灵敏的分析方法
检测几种不同损伤的修复情况,包括嘧啶
二聚体和链间交链,在来自
基因组的特定区域,我们将比较它们的速率和
不同表达水平的基因的修复程度,时间
复制、基因组位置和功能。示例包括
原癌基因和其他可诱导或发育激活的基因
金属硫蛋白、甲胎蛋白、胎儿
与成体β-珠蛋白和肌球蛋白重链的分化
成肌细胞。染色质构象和甲基化水平将
被评估为熟练维修的可能决定因素。修补
而突变将在相同的基因中相互关联
确定差异修复是否可能解释
与致癌相关的诱变变化。复制
已定义的含有损伤的核苷酸序列将被研究以
确定中是否存在差异级别的复制
特定的基因组结构域和子链是否
在这些序列中会出现不连续。定义嵌合体
含有独特部位损伤的质粒将被用来
将基因导入不同的基因组结构域并探索
损伤处理的特定特征增加了频率
人类细胞的稳定转化。
这项研究应该对我们的理解有很大的帮助
DNA损伤处理缺陷的基础在某些方面
易患癌症的遗传性疾病,它还应该导致新的,
用于人体损伤与修复分析的灵敏探针
细胞。此外,我们的研究应该有助于解释
生物终点的DNA损伤,如存活、突变、
和致癌作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP COURTLAND HANAWALT其他文献
PHILIP COURTLAND HANAWALT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP COURTLAND HANAWALT', 18)}}的其他基金
2014 DNA Damage, Mutation and Cancer Gordon Research Conference
2014 年 DNA 损伤、突变和癌症戈登研究会议
- 批准号:
8641449 - 财政年份:2014
- 资助金额:
$ 69.22万 - 项目类别:
Oxidative DNA damage processing; role in human pathology and aging
DNA氧化损伤处理;
- 批准号:
7861977 - 财政年份:2010
- 资助金额:
$ 69.22万 - 项目类别:
Oxidative DNA damage processing; role in human pathology and aging
DNA氧化损伤处理;
- 批准号:
8214492 - 财政年份:2010
- 资助金额:
$ 69.22万 - 项目类别:
Oxidative DNA damage processing; role in human pathology and aging
DNA氧化损伤处理;
- 批准号:
8417614 - 财政年份:2010
- 资助金额:
$ 69.22万 - 项目类别:
Oxidative DNA damage processing; role in human pathology and aging
DNA氧化损伤处理;
- 批准号:
8056028 - 财政年份:2010
- 资助金额:
$ 69.22万 - 项目类别:
Oxidative DNA damage processing; role in human pathology and aging
DNA氧化损伤处理;
- 批准号:
8609029 - 财政年份:2010
- 资助金额:
$ 69.22万 - 项目类别:
9th International Conference on Environmental Mutagens
第九届国际环境诱变剂会议
- 批准号:
7000991 - 财政年份:2005
- 资助金额:
$ 69.22万 - 项目类别:
Transcription Coupled DNA Repair and Human Disease
转录耦合 DNA 修复与人类疾病
- 批准号:
6426802 - 财政年份:2002
- 资助金额:
$ 69.22万 - 项目类别:
Transcription coupled DNA repair in E. Coli
大肠杆菌中的转录耦合 DNA 修复
- 批准号:
6621077 - 财政年份:2002
- 资助金额:
$ 69.22万 - 项目类别:
Transcription Coupled DNA Repair and Human Disease
转录耦合 DNA 修复与人类疾病
- 批准号:
6620051 - 财政年份:2002
- 资助金额:
$ 69.22万 - 项目类别:
相似海外基金
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
- 批准号:
10991546 - 财政年份:2024
- 资助金额:
$ 69.22万 - 项目类别:
The shielding role of the nuclear periphery against the genetic and non-genetic consequences of DNA damage (ChromoSENSOR)
核外围对 DNA 损伤的遗传和非遗传后果的屏蔽作用 (ChromoSENSOR)
- 批准号:
EP/Y027124/1 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
Research Grant
Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability
ATR 在跨损伤合成中的作用对预防 DNA 损伤诱导的突变和染色体不稳定性的影响
- 批准号:
10634852 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factor
转录、DNA 损伤和表观遗传学的界面:EWS-FLI1 转录因子的治疗脆弱性
- 批准号:
10718793 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
Role of DNA damage and cellular senescence in osteoarthritis pathophysiology
DNA 损伤和细胞衰老在骨关节炎病理生理学中的作用
- 批准号:
10801026 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
Elucidation of the mechanism underlying cellular senescence and aging induced by the continuous DNA damage
阐明持续DNA损伤引起的细胞衰老和老化的机制
- 批准号:
22KJ0646 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Targeting the function of BRCA1 in the DNA damage response network.
靶向 DNA 损伤反应网络中 BRCA1 的功能。
- 批准号:
2879783 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:
Studentship
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
TAZ 和 YAP 在 3D 基因组组织 DNA 损伤修复中的新作用以及胶质母细胞瘤的治疗耐药性
- 批准号:
10649830 - 财政年份:2023
- 资助金额:
$ 69.22万 - 项目类别:














{{item.name}}会员




